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Using a pituitary tumour cell line (GH3), we have studied the phosphorylation f intracellular proteins in- 
duced by phorbol esters of diverse biological activity. All the active phorbol esters, including the weakly 
tumour-promoting but non-platelet aggregatory compound DOPPA, stimulated the phosphorylation f a 
cytosolic 80 kDa protein. A protein of this molecular mass has been suggested to be a marker of PKC activi- 
ty. In contrast, only TPA and the non-tumour promoting but highly active phorbol ester SAP A stimulated 
the phosphorylation f a 130 kDa membrane protein. The results uggest that these phorbol esters activate 
PKC, but induce the differential phosphorylation f a variety of intracellular proteins. 
Protein kinase C; Phorbol ester; Protein phosphorylation 
1. INTRODUCTION 
On binding to their receptor, a wide variety of 
hormones, neurotransmitters and growth factors 
stimulate the hydrolysis of the phosphoinositides 
by activation of phospholipase C. This enzyme 
hydrolyses phosphatidylinositol 4,5-bisphosphate 
to yield the two second messengers inositol 
1,4,5-trisphosphate and diacylglycerol. IP3 has 
been shown to be responsible for the rise in in- 
tracellular Ca 2+ levels, whereas DAG provides the 
signal for the transmembrane control of protein 
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phosphorylation by activation of the Ca z+- and 
phospholipid-dependent protein kinase C. At low 
concentrations, DAG increases the affinity of PKC 
for Ca 2+ and phospholipid, and renders the en- 
zyme fully active in the absence of a further rise in 
Ca z+ levels. The enzyme then migrates to the 
plasma membrane where it exerts its full enzymatic 
activity [1 ]. 
Investigation i to the role of PKC within the cell 
has been made considerably easier since the 
discovery that certain naturally occurring phorbol 
esters are able to activate PKC [2]. Subsequent 
studies have shown that the phorbol ester receptor 
co-purifies with PKC [3] and have provided fur- 
ther evidence that the phorbol esters directly ac- 
tivate PKC by substituting for DAG [4]. Phorbol 
esters are a group of toxic diterpenes i olated from 
the plant families Euphorbiaceae and Thymele- 
aceae. Biologically active phorbol esters have 
been shown to induce lymphocyte mitogenesis, 
stimulate platelet aggregation, increase the produc- 
tion of prostaglandin El, possess tumour- 
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promoting and pro-inflammatory activity, induce 
changes in phospholipid metabolism and protein 
synthesis, alter rates of DNA synthesis, affect 
polyamine biosynthesis and produce changes in 
cell morphology (reviews [5,6]). Our interest in this 
field lies in the use of the phorbol esters of diverse 
biological activity to determine substrate proteins 
for PKC which are involved in enzyme cascades 
leading to specific biological effects such as secre- 
tion and tumour promotion. Several substrate pro- 
teins have been identified in vitro, although only a 
few of these have been identified as in vivo 
substrates for the enzyme [7]. 
In the present study we have used the rat 
pituitary tumour cell line, GH3. In these cells, 
phorbol esters have little effect on cell growth 
although they do stimulate growth hormone and 
prolactin secretion, as well as enhance the produc- 
tion of prolactin. Other effects include decreased 
thyrotropin releasing hormone (TRH), epidermal 
growth factor and somatostatin binding (review 
[8]). The pituitary peptide TRH has also been 
shown to induce prolactin and growth hormone 
secretion [9] by a mechanism which is believed to 
utilize the phosphoinositide hydrolysis pathway 
[10,11]. A small number of proteins have been 
shown to be phosphorylated in response to TPA 
treatment in both GH3 and the related GH4CI cells 
[12,13]. This is a potent phorbol ester, capable of 
inducing a broad spectrum of biological effects in- 
cluding platelet aggregation, tumour promotion 
and inflammation [5,6]. In order to identify 
substrates which may be involved in a particular 
biochemical response, we utilized three phorbol 
esters which have narrower spectra of activity, 
SAP A, DOPPA and o~-SAP Ac. SAP A is an ex- 
tremely potent inflammatory agent which also 
possesses platelet aggregatory and other properties 
similar to TPA. However, we have recently shown 
that SAP A is neither a first nor second stage 
tumour-promoting agent [14]. DOPPA has been 
shown to be weakly tumour-promoting [15] but 
non-platelet aggregatory [16], whereas o~-SAP Ac 
possesses no biological activity [6] (see table 1). 
Consequently, it is of great interest to show 
whether these phorbol esters and TRH induce pat- 
terns of protein phosphorylation different to that 
of TPA. 
2. MATERIALS AND METHODS 
Ampholytes were obtained from LKB, KC1, 
NaC1, SDS, glucose, glycine, MgCI2, CaCI2 and 
glycerol were from BDH. 32p i was from Amer- 
sham International. Penicillin/streptomycin solu- 
tion, donor horse serum, fetal calf serum and 
Ham's  F10 culture medium were obtained from 
Gibco. The phorbol esters SAP A, c~-SAP Ac and 
DOPPA were isolated as reported [17-19]. TRH 
and GH3 cells were kindly donated by A.H. Drum- 
mond. All other reagents were obtained from 
Sigma. 
2.1. Cell culture 
GH3 cells were grown in monolayer culture at 
37°C under 95% air/5o70 CO2 on 10 cm dishes in 
9 ml of Ham's  F10 culture medium, supplemented 
with 15% donor horse serum, 2.5% fetal calf 
serum, 100 IU/ml  penicillin and 100/~g/ml strep- 
tomycin, and 6.25/~g/ml neomycin. The cultures 
were refed at 3-4 day intervals for 10 days. 
2.2. 32Pi incorporation 
Prior to labelling, cells were scraped off the 
dishes using a rubber policeman and were washed 
with balanced salt solution (135mM NaC1, 
4.5 mM KC1, 1.5 mM CaCI2, 0.5 mM MgC12, 
5.6 mM glucose, 10 mM Hepes, pH 7.4, 0.1070 
bovine serum albumin, 0.01070 sodium pyruvate). 
Cells were resuspended in this solution, incubated 
with 20/~Ci/ml 32pi for 1 h at 37°C and stimulated 
with various agents for the indicated times. 
2.3. Sample preparation for one-dimensional gel 
electroph oresis 
Following phorbol ester stimulation, cells were 
rapidly washed with ice cold 0.3 M sodium 
phosphate and 0.15 M NaC1, and resuspended in a 
final volume of 50/A of the same solution. The 
cells were rapidly frozen on dry ice then thawed in 
50/A of a protease/phosphatase inhibitor solution 
containing 0.2 M NaF, 20 mM EDTA, 50 mM 
Hepes, pH 7.5, and 1 mM 2-mercaptoethanol. All 
subsequent procedures were carried out at 4°C 
unless otherwise stated. The suspension was 
sonicated for 3 s using an MSE ultrasonic power 
unit - a procedure which has been reported to lyse 
cells but leave nuclei intact. The cell suspension 
was centrifuged at 15000 x g for 5 min using a 
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Heraeus Christ Biofuge to pellet cell debris and 
nuclei. The resultant supernatant, which contained 
the cytoplasm and membrane fragments, was then 
centrifuged at 100000 × g for 20 min in a Beckman 
Airfuge to yield a supernatant ( he 'cytoplasmic' 
fraction) and a pellet (the 'membrane' fraction). 
The membrane fraction was resuspended in 100/A 
of 100 mM NaF, 10 mM EDTA, 0.5 mM 
2-mercaptoethanol and 25 mM Hepes, pH 7.5. 
Both fractions were solubilized with 100,ul sample 
buffer (0.125 M Tris-HC1, pH 6.8, 4°7o SDS, 20O/o 
glycerol, 10% 2-mercaptoethanol, 0.00207o bromo- 
phenol blue) at 100°C for 5 min. The suspension 
was centrifuged at 100000 × g for 20 min using a 
Beckman Airfuge. The resultant supernatant was 
counted for radioactivity by Cherenkov counting 
on an LKB rack-beta liquid scintillation counter. 
Equal counts were loaded onto one-dimensional 
SDS-polyacrylamide g ls and run according to the 
method of Laemmli [20]. Proteins were resolved 
on 10°70 polyacrylamide slab gels at 45 mA con- 
stant current unless otherwise stated. Standard 
molecular mass markers used to calibrate the gels 
were myosin (205 kDa), ~-galactosidase (116 kDa), 
phosphorylase b (98 kDa), bovine serum albumin 
(68 kDa) and carbonic anhydrase (29 kDa). After 
staining with Coomassie blue and drying, gels were 
autoradiographed using Kodak X-Omat S film 
with an intensifying screen at -70°C.  
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Fig.1. Autoradiographs of cytosolic (a) and membrane (b) proteins from GH3 cells following treatment with various 
phorbol esters. Cells were labelled with 32pi for 1 h, and incubated with no further additions (control), TPA (100 nM), 
SAP A (100 nM), DOPPA (300 nM) or o~-SAP Ac (500 riM) for 10 min. The reaction was terminated by washing the 
cells in ice-cold PBS followed by lysis into a protease/phosphatase inhibitor solution. The lysate was centrifuged at 
100000 × g for 20 min to yield a supernatant cytosolic fraction and membrane pellet. These fractions were analysed 
by SDS-gel electrophoresis using a 10% acrylamide resolving gel. 
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2.4. Sample preparation for two-dimensional ge
electrophoresis 
Following phorbol ester stimulation cells were 
rapidly washed in phosphate buffered saline (PBS) 
containing 100 mM NaF and 10 mM EDTA, and 
resuspended in 50/21 of  this solution with 20/A of  
leupeptin solution (1 mg/ml  in 20 mM Tris-HC1, 
pH 7.0). Cells were homogenized by rapid freez- 
ing, thawing and sonicating as before. Subcellular 
fractions were prepared as for one-dimensional 
gels with the exception that the membrane fraction 
was resuspended in 50/,1 of  PBS containing 
100 mM NaF, 10 mM EDTA and 20/A of the 
leupeptin solution. To both fractions, 100/A of  a 
micrococcal nuclease solution (100/~g/ml in 
20 mM Tris-HC1, pH 8.8, 2 mM CaCI2), 20/A of 
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Fig.2. Densitometric scans of autoradiographs shown in fig. 1. In each case, phorbol ester incubations are superimposed 
onto those of control scans, with increases in phosphate incorporation being represented by the shaded areas. Molecular 
masses of each protein peak are indicated by the figures in a(i) and b(i). 
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solubilizer (2O7o SDS, 0.5 mM MgCI2, 50 mM Tris- 
HC1, pH 7.0) and 10/A of a DNase/RNase solu- 
tion (2 mg/ml DNase, 1 mg/ml  RNase, 0.5 M 
Tris-HCl, pH 7.0, 50 mM MgClz) were added, and 
incubated at 4°C for 10 min. The suspension was 
heated at 100°C for 15 min before lyophilizing. 
The residue was resuspended in 40/A dilution buf- 
fer (9.5 M urea, 2°7o ampholytes, 5°7o 2-mercapto- 
ethanol and 8°70 NP-40). Samples were then spun 
at 100000 × g for 20 min using a Beckman Airfuge 
and the supernatant was counted for radioactivity. 
Equal counts were analysed by 2-dimensional gel 
electrophoresis [21] using 7.5 cm isoelectric 
focussing gels of the ampholyte composition pH 
2 .5 -4 :4 -6 :5 -7 :3 .5 -10 ,  2 :2 :2 :1 .  
3. RESULTS 
Several proteins have shown an increase in 
phosphorylation state in response to phorbol ester 
treatment of intact GH3 cells. The autoradiographs 
of one-dimensional gels of cytosolic and mem- 
brane proteins phosphorylated in response to treat- 
ment with phorbol esters are shown in fig. l a and 
b. The corresponding densitometer scans are 
shown in fig.2a and b. 
It would appear that the non-tumour promoting 
phorbol ester, SAP A, induces a very similar pat- 
tern of cytosolic and membrane protein 
phosphorylation to TPA although at the concen- 
tration used (100 nM), there is greater 
phosphorylation of some membrane proteins than 
that induced by the same dose of TPA. Both TPA 
and SAP A have similar Ka values for the activa- 
tion of PKC (see table 1). In contrast, the 
phosphorylation pattern seen in response to 
DOPPA is markedly different. Using a dose of 
300 nM, there is an obvious lack of phosphoryla- 
tion of all membrane proteins above basal levels 
(fig.2b), although there is a detectable increase in 
the phosphorylation state of a 82 kDa cytosolic 
protein (fig.la). The phosphorylation pattern in- 
duced by the biologically inactive phorbol ester, ce- 
SAP Ac shows some similarities to that of 
DOPPA.  However, the former compound does 
not induce the phosphorylation of the 82 kDa 
cytosolic protein (fig.la), but does increase the 
phosphorylation state of a few lower molecular 
mass membrane proteins (figs lb,2b). Unlike the 
phosphorylation patterns induced by the active 
phorbol esters TPA and SAP A, there is no 
evidence of phosphorylation of the 130 kDa mem- 
brane protein. Indeed, phosphate incorporation in 
this region appears to be reduced below basal 
levels. At the dose used in the present study 
(500 nM), c~-SAP Ac has been reported to induce 
virtually no activation of PKC in vitro [22,23], 
although at doses higher than 1/~M some stimula- 
tion is seen. 
To characterize further the proteins whose state 
of phosphorylation is differentially enhanced by 
phorbol esters of distinct biological activity we 
analysed subsequent subcellular fractions by two- 
dimensional gel electrophoresis. Both TPA and 
DOPPA stimulate the phosphorylation of proteins 
of molecular masses 23, 25 and 80 kDa, whereas 
Table 1 
Compound Lymphocyte Pro-inflam- Human platelet Prostaglandin Protein k ase Phorbol dibu- 
mitogenesis matory activity aggregation E2 production C stimulation tyrate binding 
[61 [61 [3 I I [6] [301 assay [23] 
EO4o (ng/ml) IDso (~g) EDso (,aM) ED4 (ng/ml) Ka (nM) ICs0 (nM) 
TPA 17 0.007 0.30 0.28 17 0.8 
SAP A 34 0.02 1.76 0.26 36 22 
DOPPA 564 0.04 - ve 46.0 100 240 
ce-SAP Ac - - - ve - 2600 10000 
The compound TPA is a known tumour-promoting a ent. Lymphocyte mitogenesis values are EC4o ng/ml. Pro- 
inflammatory activity is IDs0/~g/ear, values more than 10/~g/ear are shown as negative (-ve). Platelet aggregation is 
EDso/~M. Values greater than 8/~M are shown as negative ( -  ve). ED4 is the dose of phorbol ester equired to raise 
the basal level of PGE2 4-fold in human rheumatoid synovial cells. The phorbol dibutyrate binding values are shown 
as negative if more than 40/~M. ( - )  Figures not available 
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TPA additionally stimulates the phosphorylation 
of a 20 kDa protein(s) (fig.3). Incubation with 
TRH also resulted in increased phosphorylation of
the 80 kDa protein although there was no detect- 
able increase in phosphate incorporation into the 
23 and 25 kDa proteins as seen with DOPPA and 
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Fig.3. Autoradiograph of cytosolic proteins of GH3 cells 
analysed by 2D-SDS gel electrophoresis. Gels were 
labelled for 1 h with 32pi and incubated with no further 
addition (control), TPA (100 nM), DOPPA (300 nM) 
and TRH (10 -7 M) for 10min. The reaction was 
terminated by washing with ice-cold PBS and lysing the 
cells into a protease/phosphatase inhibitor solution. The 
lysate was centrifuged to yield the cytosolic supernatant. 
These fractions were lyophilized, solubilized and 
analysed by 2D-SDS gel electrophoresis using 10°70 
acrylarnide resolving gels. Proteins which show 
differences in phosphorylation following phorbol ester 
on TRH treatment are indicated by arrows on the 
control autoradiograph. 
TPA. Additionally, treatment with both TPA and 
TRH, but not DOPPA appears to induce a reduc- 
tion in the phosphorylation of a 52 kDa protein(s) 
to below basal levels. 
4. DISCUSSION 
We have shown that a variety of phorbol esters 
differentially induce the phosphorylation of 
several cytosolic and membrane proteins in vivo. 
The reasons for the increase in phosphorylation i  
response to the supposedly inactive phorbol ester 
o~-SAP Ac remains unclear. It is unlikely that this 
compound is degraded to an active metabolite as 
phorbol esters possessing the a,-configuration are 
inherently inactive [6]. On the other hand, 
DOPPA shows poorer stimulation of protein 
phosphorylation, more in line with what would be 
expected from a phorbol ester with limited 
biological activity (see table 1). However, we have 
shown that this compound is capable of activating 
PKC in vitro, albeit at relatively high doses 
[22,23]. Consequently, at the dose used (300 nM), 
there is likely to be some activation of PKC with 
the resultant increase in substrate phosphoryla- 
tion. As this compound is only weakly tumour- 
promoting and non-platelet aggregatory, it is im- 
probable that the proteins phosphorylated in 
response to this phorbol ester (e.g. 82 kDa) are im- 
portant regulatory enzymes for these biological 
effects. 
A similar set of cytosolic proteins has been 
reported to be phosphorylated in response to TRH 
and TPA stimulation of GH3 cells [12,24]. This 
peptide hormone stimulates phosphoinositide 
metabolism to yield the two intracellular second 
messengers IP3 and DAG [10,11]. Consequently, it 
is likely that TRH acts by stimulating both 
CaZ+-calmodulin dependent protein kinase and 
PKC. Indeed, it has been shown that PKC is 
responsible for some of the increases in protein 
phosphorylation seen on addition of TRH,  as TPA 
treatment induces the phosphorylation of 5 of the 
7 proteins induced by TRH [12]. These cytosolic 
proteins have molecular masses of 59 kDa (two 
bands), 65, 80 and 82 kDa, and there is also a 
reported decrease in the phosphorylation of a 
55 kDa protein in response to treatment with TRH 
[24]. TPA treatment of cells in our system resulted 
in an increase in phosphate incorporation nto 
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cytosolic proteins of molecular masses 23, 25 and 
80 kDa, and a decrease of phosphorylation f two 
52 kDa proteins. Additionally, a 135 kDa pellet 
protein has been shown to be phosphorylated in
response to both TRH and TPA [24]. This could 
correspond to the 130 kDa membrane protein 
phosphorylated in response to TPA treatment in 
our system. Interestingly, this protein is also 
phosphorylated following treatment of the cells 
with the non-tumour-promoting phorbol ester 
SAP A, but not by DOPPA or o~-SAP Ac. A pro- 
tein of this molecular mass has been identified as 
vinculin, a cytoskeletal protein which is believed to 
be involved in the attachment of actin to mem- 
branes, and has also been shown to be a substrate 
for PKC both in vitro [25] and in vivo [26]. 
Other proteins of interest include the two 
20 kDa proteins that appear to be exclusively 
phosphorylated in the presence of TPA, and the 
52 kDa protein(s) whose phosphorylation state is 
to be altered in response to TPA and TRH treat- 
ment, but not by the phorbol ester of limited 
biological activity, DOPPA. It remains to be seen 
if the 52 kDa phosphoprotein corresponds to the 
55 kDa protein previously reported to be 
dephosphorylated following incubation with TRH 
and TPA [24]. 
Explanations for the observed differences in- 
clude the possibilities that the phorbol esters may 
alter the substrate specificity of the enzyme, or that 
the phorbol esters are activating isozymes of PKC 
[27] with different affinities. Heterogeneity of 
TPA and [3H]phorbol dibutyrate binding in vivo 
and in vitro has previously been observed [28]. 
However, our results of the [3H]phorbol 
dibutyrate binding assay indicate that all the phor- 
bol esters bind to the same site on rat brain PKC 
preparations [23]. It appears that the majority of 
substrates for this protein kinase are cytosolic, 
which is somewhat surprising considering that the 
active form of PKC is attached to the plasma mem- 
brane [28]. It has been shown that in addition to 
inducing the relocalization of PKC to the mem- 
brane, TPA is also capable of inducing proteolysis 
of the enzyme to a cytoplasmic ofactor indepen- 
dent form [29]. 
In order to gain further insight into the role of 
these phosphoproteins in the induction of cellular 
events it is important o correlate phosphorylation 
of particular proteins with specific cellular 
responses uch as changes in morphology, prolac- 
tin synthesis and secretion. Ultimately, our aim is 
to fully characterize the proteins which mediate 
these specific biological events. 
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